449 related articles for article (PubMed ID: 23147245)
41. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma.
Cheville JC; Lohse CM; Zincke H; Weaver AL; Blute ML
Am J Surg Pathol; 2003 May; 27(5):612-24. PubMed ID: 12717246
[TBL] [Abstract][Full Text] [Related]
42. Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome.
Krejci KG; Blute ML; Cheville JC; Sebo TJ; Lohse CM; Zincke H
Urology; 2003 Oct; 62(4):641-6. PubMed ID: 14550434
[TBL] [Abstract][Full Text] [Related]
43. Morphologic subtyping as a prognostic predictor for survival in papillary renal cell carcinoma: Type 1 vs. type 2.
Wong ECL; Di Lena R; Breau RH; Pouliot F; Finelli A; Lavallée LT; So A; Tanguay S; Fairey A; Rendon R; Richard PO; Lattouf JB; Kawakami J; Mallick R; Kapoor A
Urol Oncol; 2019 Oct; 37(10):721-726. PubMed ID: 31176614
[TBL] [Abstract][Full Text] [Related]
44. Prognostic significance of extensive necrosis in renal cell carcinoma.
Collins J; Epstein JI
Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
[TBL] [Abstract][Full Text] [Related]
45. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
46. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.
Lau WK; Cheville JC; Blute ML; Weaver AL; Zincke H
Urology; 2002 Apr; 59(4):532-7. PubMed ID: 11927308
[TBL] [Abstract][Full Text] [Related]
47. Temporal change in risk of metachronous contralateral renal cell carcinoma: influence of tumor characteristics and demographic factors.
Rabbani F; Herr HW; Almahmeed T; Russo P
J Clin Oncol; 2002 May; 20(9):2370-5. PubMed ID: 11981010
[TBL] [Abstract][Full Text] [Related]
48. Vascular cell adhesion molecule 1 predicts cancer-free survival in clear cell renal carcinoma patients.
Shioi K; Komiya A; Hattori K; Huang Y; Sano F; Murakami T; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
Clin Cancer Res; 2006 Dec; 12(24):7339-46. PubMed ID: 17189405
[TBL] [Abstract][Full Text] [Related]
49. Cigarette smoking and renal cell carcinoma risk among black and white Americans: effect modification by hypertension and obesity.
Cote ML; Colt JS; Schwartz KL; Wacholder S; Ruterbusch JJ; Davis F; Purdue M; Graubard BI; Chow WH
Cancer Epidemiol Biomarkers Prev; 2012 May; 21(5):770-9. PubMed ID: 22426145
[TBL] [Abstract][Full Text] [Related]
50. Prognostic analysis of postoperative clinically nonmetastatic renal cell carcinoma.
Shao Y; Xiong S; Sun G; Dou W; Hu X; Yang W; Lia T; Deng S; Wei Q; Zeng H; Li X
Cancer Med; 2020 Feb; 9(3):959-970. PubMed ID: 31840431
[TBL] [Abstract][Full Text] [Related]
51. Age, tumor size and relative survival of patients with localized renal cell carcinoma: a surveillance, epidemiology and end results analysis.
Scoll BJ; Wong YN; Egleston BL; Kunkle DA; Saad IR; Uzzo RG
J Urol; 2009 Feb; 181(2):506-11. PubMed ID: 19084868
[TBL] [Abstract][Full Text] [Related]
52. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma.
Beck SD; Patel MI; Snyder ME; Kattan MW; Motzer RJ; Reuter VE; Russo P
Ann Surg Oncol; 2004 Jan; 11(1):71-7. PubMed ID: 14699037
[TBL] [Abstract][Full Text] [Related]
53. The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment.
Bhindi B; Thompson RH; Lohse CM; Mason RJ; Frank I; Costello BA; Potretzke AM; Hartman RP; Potretzke TA; Boorjian SA; Cheville JC; Leibovich BC
Eur Urol; 2018 Oct; 74(4):489-497. PubMed ID: 30017400
[TBL] [Abstract][Full Text] [Related]
54. Racial Diversity Among Histology of Renal Cell Carcinoma at an Urban Medical Center.
Wong KJ; Shusterman M; Goel S; Negassa A; Lin J; Gartrell BA
Clin Genitourin Cancer; 2021 Jun; 19(3):e166-e170. PubMed ID: 33602582
[TBL] [Abstract][Full Text] [Related]
55. The Association Between Race and 5-year Survival in Patients With Clear Cell Renal Cell Carcinoma: A Cohort Study.
Jivanji D; Jamieson S; Mallory C; Wong V; Barrau S; Atri E; Castro G; Barengo NC; Nieder AM
Urology; 2021 Feb; 148():185-191. PubMed ID: 33285213
[TBL] [Abstract][Full Text] [Related]
56. Understanding racial disparities in renal cell carcinoma incidence: estimates of population attributable risk in two US populations.
Callahan CL; Schwartz K; Corley DA; Ruterbusch JJ; Zhao WK; Shuch B; Graubard BI; Rothman N; Chow WH; Silverman DT; Purdue MP; Hofmann JN
Cancer Causes Control; 2020 Jan; 31(1):85-93. PubMed ID: 31782041
[TBL] [Abstract][Full Text] [Related]
57. Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses.
Gillett MD; Cheville JC; Karnes RJ; Lohse CM; Kwon ED; Leibovich BC; Zincke H; Blute ML
J Urol; 2005 Jun; 173(6):1893-6. PubMed ID: 15879770
[TBL] [Abstract][Full Text] [Related]
58. Racial Disparities in Histology and Short-Term Renal Functional Outcomes Following Robotic Nephron-Sparing Surgery.
Wang JC; Lai WR; Traore EJ; Liu J; Sholl AB; Mandava SH; Maddox MM; Mitchell GC; Viriyasiripong S; Silberstein JL; Kittles R; Lee BR
Clin Genitourin Cancer; 2017 Apr; 15(2):203-206. PubMed ID: 27554583
[TBL] [Abstract][Full Text] [Related]
59. Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics.
Eisenberg MS; Leibovich BC; Kim SP
Cancer; 2013 Aug; 119(16):3100. PubMed ID: 23696039
[No Abstract] [Full Text] [Related]
60. Gender-specific clinicopathological features and survival in patients with renal cell carcinoma (RCC).
Lee S; Jeon HG; Kwak C; Kim HH; Byun SS; Lee SE; Lee E
BJU Int; 2012 Jul; 110(2 Pt 2):E28-33. PubMed ID: 22085161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]